[Multiple myeloma with antinuclear antibodies. Its course during cytostatic therapy]

Dtsch Med Wochenschr. 1992 May 22;117(21):819-22. doi: 10.1055/s-2008-1062381.
[Article in German]

Abstract

A 56-year-old man complained of general malaise, diffuse bone pain, nocturnal sweating, lack of appetite and weight loss (7 kg within one year). Pain in the pelvic and lumbar regions markedly impaired movement. Roentgenologically, multiple lucencies were visualised in many skeletal areas. Examination of the bone marrow revealed an increase in the proportion of atypical plasma cells to 40%. The IgG concentration was 29.8 milligrams, mainly monoclonal immunoglobulins of the IgG-kappa type, which reacted against nuclear antigens (68-kD-U1-RNP nuclear protein) with a 1:2,000 titre. The symptoms markedly regressed under cyclical combined therapy with three times 5 mg melphalan daily for 4 days and 100 mg prednisolone daily for 7 days (a total of 24 cycles). At the same time the IgG concentration and the autoantibody titre decreased markedly and the patient became symptom-free.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antibodies, Antinuclear / blood
  • Antibodies, Antinuclear / drug effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Immunoglobulin kappa-Chains / blood
  • Immunoglobulin kappa-Chains / drug effects
  • Male
  • Melphalan / administration & dosage
  • Middle Aged
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / immunology*
  • Prednisolone / administration & dosage
  • Time Factors

Substances

  • Antibodies, Antinuclear
  • Immunoglobulin kappa-Chains
  • Prednisolone
  • Melphalan